Reduced pancreatic polypeptide response to hypoglycemia and amylin response to arginine in subjects with a mutation in the HNF-4α/MODY1 gene

Diabetes

Volumn 49, Issue 6, 2000, Pages 961-968

  Ilag, Liza L ^a   Tabaei, Bahman P ^a   Herman, William H ^a   Zawacki, Catherine M ^a   D'Souza, Estelle ^a   Bell, Graeme I ^b   Fajans, Stefan S ^a,c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLIN; ARGININE; C PEPTIDE; GLUCAGON; INSULIN; NUCLEAR FACTOR I; PANCREAS POLYPEPTIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; GLUCAGON RELEASE; GLUCOSE BLOOD LEVEL; HORMONE RESPONSE; HUMAN; HUMAN CELL; HYPOGLYCEMIA; INSULIN RELEASE; MALE; MATURITY ONSET DIABETES MELLITUS; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PEDIGREE; PRIORITY JOURNAL;

EID: 0034119275     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.49.6.961     Document Type: Article

References (42)

1. Fajans SS: Scope and heterogeneous nature of maturity-onset diabetes of the young (MODY). Diabetes Care 13:49-64, 1990 (Erratum Diabetes Care 13:910, 1990)
2. Fajans SS, Bell GI, Bowden DW, Halter JB, Polonsky KS: Maturity-onset diabetes of the young. Life Sci 55:413-422, 1994
3. Herman WH, Fajans SS, Ortiz FJ, Smith MJ, Sturis J, Bell GI, Polonsky KS, Halter JB: Abnormal insulin secretion, not insulin resistance is the genetic or primary defect of MODY in the RW pedigree. Diabetes 43:40-46, 1994
4. Yamagata K, Furuta H, Oda N, Kaisaki PJ, Menzel S, Cox NJ, Fajans SS, Signorini S, Stoffel M, Bell GI: Mutations in the hepatocyte nuclear factor-4α gene in maturity-onset diabetes of the young (MODY1). Nature 384:458-460, 1996
5. Froguel P, Vaxillaire M, Sun F, Velho G, Zouali H, Butel MO, Leasge S, Vionnet N, Clement K, Fougerousse F, Tanizawa Y, Weissebach J, Beckmann JS, Lathrop GH, Passa P, Permutt MA, Cohen D: Close linkage of glucokinase locus on chromosome 7p to early onset non-insulin dependent diabetes mellitus. Nature 356:162-164, 1992
6. Yamagata K, Oda N, Kaisaki PJ, Menzel S, Furuta H, Vaxillaire M, Southam L, Cox RD, Lathrop GM, Boriraj VV, Chen X, Cox NJ, Oda Y, Yano H, Le Beau MM, Yamada S, Nishigori H, Takeda J, Fajans SS, Hattersley AT, Iwasaki N, Hansen T, Pedersen O, Polonsky KS, Turner RC, Velho G, Chevre J, Froguel P, Bell GI: Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY3). Nature 384:455-458, 1996
7. Stoffers DA, Ferrer J, Clarke WL, Habener JF: Early-onset type-II diabetes mellitus (MODY4) linked to IPF1. Nat Genet 17:138-139, 1997
8. Horikawa Y, Iwasaki N, Hara M, Furuta H, Hinokio Y, Cockburn BN: Mutation in hepatocyte nuclear factor-1β gene (TCF2) associated with MODY. Nat Genet 17:384-385, 1997
9. Herman WH, Fajans SS, Smith MJ, Polonsky KS, Bell GI, Halter JB: Diminished insulin and glucagon secretory responses to arginine in nondiabetic subjects with a mutation in the hepatocyte nuclear factor-4α/MODY1 gene. Diabetes 46:1749-1754, 1997
10. Floyd JC Jr, Fajans SS, Pek S, Chance RE: A newly recognized pancreatic polypeptide: plasma levels in health and disease. Recent Prog Horm Res 33:519-570, 1976
11. Schwartz TW, Rehfeld JF, Stadil F, Larsson LI, Chance RE, Moon N: Pancreatic polypeptide response to food in duodenal-ulcer patients before and after vagotomy. Lancet i: 1102-1105, 1976
12. Levitt NS, Vinik AI, Sive AA, Van Tonder S, Lund A: Impaired pancreatic polypeptide responses to insulin-induced hypoglycemia in diabetic autonomic neuropathy. J Clin Endocrinol Metab 50:445-449, 1980
13. Cooper GJS, Leighton B, Dimitriadis GD, Parry-Billings M, Kowalchuk JM, Gowland K, Rothbard JB, Willis AD, Reid KBM: Amylin found in amyloid deposits in human type 2 diabetes mellitus may be a hormone that regulates glycogen metabolism in skeletal muscle. Proc Natl Acad Sci U S A 85:7763-7766, 1988
14. Westermark P, Wernstedt C, O'Brien TD, Hayden DW, Johnson KH: Islet amyloid in type 2 human diabetes mellitus and adult diabetic cats contains a novel putative polypeptide hormone. Am J Pathol 127:414-417, 1987
15. Castillo MJ, Scheen AJ, Lefebvre PJ: Amylin/islet amyloid polypeptide: biochemistry, physiology, patho-physiology. Diabete Metab 21:3-25, 1995
16. O'Brien TD, Butler PC, Westermark P, Johnson KH: Islet amyloid polypeptide: a review of its biology and potential roles in the pathogenesis of diabetes mellitus. Vet Pathol 30:317-332, 1993
17. Nishi M, Sanke T, Seino S, Eddy RL, Fan Y-S, Byers MG, Shows TB, Bell GI, Steiner DF: Human islet amyloid polypeptide gene: complete nucleotide sequence, chromosomal localization, and evolutionary history. Mol Endocrinol 3:1775-1781, 1989
18. Percy AJ, Trainor DA, Rittenhiuse J, Phelps J, Koda JE: Development of sensitive immunoassays to detect amylin and amylin-like peptides in unextracted plasma, Clin Chem 42:576-585, 1996
19. Lukinius A, Wilander E, Westermark GT, Engstrom U, Westermark P: Colocalization of islet amyloid polypeptide and insulin in the B cell secretory granules of the human pancreatic islets. Diabetologia, 32:240-244, 1989
20. Scherbaum WA: The role of amylin in the physiology of glycemic control. Exp Clin Endocrinol Diabetes 106:97-102, 1998
21. Kahn SE, Andrikopoulos S, Verchere B: A long-recognized but underappreciated pathological feature of type 2 diabetes. Diabetes 48:241-253, 1999
22. Harter E, Svoboda T, Ludvik B, Schuller M, Lell B, Kuenburg E, Brunnbauer M, Woloszczuk W, Prager R: Basal and stimulated plasma levels of pancreatic amylin indicate its co-secretion with insulin in humans. Diabetologia 34:52-54, 1991
23. Sanke T, Hanabusa T, Nakano Y, Oki C, Okai K, Nishimura S, Kondo M, Nanjo K: Plasma islet amyloid polypeptide (amylin) levels and their responses to oral glucose in type 2 (non-insulin-dependent) diabetic patients. Diabetologia 34:129-132, 1991
24. Butler PC, Chou J, Carter WB, Wang Y-N, Bu B-H, Chang D, Chang J-K, Rizza RA: Effects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humans. Diabetes 39:752-756, 1990
25. Larsson H, Ahren B: Effects of arginine on the secretion of insulin and islet amyloid polypeptide in humans. Pancreas 11:201-205, 1995
26. Ludvik B, Lell B, Hartter E, Schnack C, Pranger R: Decrease of stimulated amylin release precedes impairment of insulin secretion in type 2 diabetes. Diabetes 40:1615-1619, 1991
27. Fajans SS, Bell GI: Maturity-onset diabetes of the young: a model for genetic studies of diabetes mellitus. In Diabetes Mellitus: A Fundamental and Clinical Text. Le Roith D, Olefsky JM, Taylor S, Eds. Philadelphia, Lippincott, 2000, p. 691-705. In press
28. Nyholm B, Fineman MS, Koda JE, Schmitz O: Plasma amylin immunoreactivity and insulin resistance in insulin resistant relatives of patients with noninsulin-dependent diabetes mellitus. Horm Metab Res 30:206-212, 1997
29. Fineman MS, Koda JE, Percy A, Wareham NJ, Hales CN: Elevation of high molecular weight amylin-like peptides along with proinsulin and 32,33 split proinsulin in newly diagnosed diabetics (Abstract). Diabetologia 45 (Suppl. 2):234A, 1996
30. Byrne MM, Stuns J, Fajans SS, Ortiz FJ, Stolz A, Stoffel M, Smith MJ, Bell GI, Halter JB, Polonsky KS: Altered insulin secretory responses to glucose in subjects with a mutation in the MODY1 gene on chromosome 20. Diabetes 44:699-704, 1995
31. Lehto M, Bitzén PO, Isomaa B, Wipemo C, Wessman Y, Forsblom C, Tuomi T, Taskinen MR, Groop L: Mutation in the HNF-4alpha gene affects insulin and triglyceride metabolism. Diabetes 48:423-425, 1999
32. Byrne MM, Sturis J, Clement K, Vionnet N, Pueyo ME, Stoffel M, Takeda J, Passa P, Cohen D, Bell GI, Velho G, Froguel P, Polonsky KS: Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations. J Clin Invest 93:1120-1130, 1994
33. Velho G, Froguel P, Clement K, Pueyo ME, Rakotoambinina B, Zouali H, Passa P, Cohen D, Robert JJ: Primary pancreatic beta-cell secretory defect caused by mutations in glucokinase gene in kindreds of maturity onset diabetes of the young. Lancet 340:444-448, 1992
34. Byrne MM, Sturis J, Menzel S, Yamagata K, Fajans SS, Dronsfield M, Bain SC, Hattersley AT, Velho G, Froguel P, Bell GI, Polonsky KS: Altered insulin secretory responses to glucose in diabetic and nondiabetic subjects with mutations in the diabetes mellitus susceptibility gene MODY3 on chromosome 12. Diabetes 45:1503-1510, 1996
35. Lehto M, Tuomi T, Mahtani MM, Widen E, Forsblom C, Sarelin L, Gulstrom M, Isomaa B, Lehtovirta M, Hyrkko A, Kanninen T, Orho M, Manley S, Turner RC, Brettin T, Kirby A, Thomas J, Duyk G, Lander E, Taskinen MR, Groop L: Characterization of the MODY3 phenotype: early onset diabetes caused by an insulin secretion defect. J Clin Invest 99:582-591, 1997
36. Yoshiuchi I, Yamagata K, Yang Q, Iwahashi H, Okita K, Yamamoto K, Oue T, Imagawa A, Hamaguchi T, Yamasaki T, Horikawa Y, Satoh T, Nakajima H, Miyazaki J, Higashiyama S, Miyagawa J, Namba M, Hanafusa T, Matsuzawa Y: Three new mutations in the hepatocyte nuclear factor-1α gene in Japanese subjects with diabetes mellitus: clinical features and functional characterization. Diabetologia 42:621-626, 1999
37. Shoelson SE, Polonsky KS, Nakabayashi T, Jaspan JB, Tager HS: Circulating forms of somatostatinlike immunoreactivity in human plasma Am J Physiol 250:E428-E434, 1986
38. Habener JF, Stoffers DA: A newly discovered role of transcription factors involved in pancreas development and the pathogenesis of diabetes mellitus. Proc Assoc Am Physicians 110:12-21, 1998
39. Lukinius A, Ericsson JLE, Grimelius L, Korsgren O: Ultrastructural studies on the ontogeny of fetal human and porcine endocrine pancreas, with special reference to colocalization of the four major islet hormones. Dev Biol 153:376-385, 1992
40. Chen WS, Manova K, Weinstein DC, Duncan SA, Plump AS, Prezioso VR, Bachvarova RF, Darnell JE Jr: Description of HNF-4α gene, expressed in visceral endoderm, leads to cell death in embryonic ectoderm and impaired gastrulation of mouse embryos. Genes Dev 8:2466-2477, 1994
41. Stoffers DA, Zinkin NT, Stanojevic VS, Clarke WL, Habener JF: Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence. Nat Genet 15:106-110, 1997
42. Thomaseth K, Pacini G, Clodi M, Kautzky-Willer A, Nolan JJ, Prager R, Olefsky JM, Ludvik B: Amylin release during oral glucose tolerance test. Diabet Med 14 (Suppl. 2):S29-S34, 1997